TY - JOUR
T1 - Dynamic crosstalk between GlcAcylation and phosphorylation
T2 - Roles in signaling, transcription and human disease
AU - Shimoji, Shino
AU - Park, Kyoungsook
AU - Hart, Gerald Warren
PY - 2010/1
Y1 - 2010/1
N2 - GlcNAcylation is a dynamic cytoplasmic and nuclear post-translational sugar modification of serine/threonine residues. The addition and removal of O-GlcNAc are regulated by O-GlcNAc Transferase and O-GlcNAcase, respectively. Over ~1000 proteins have been identified to be GlcNAcylated with over 240 mapped sites. O-GlcNAc is involved in critical cellular functions, such as cell-cycle regulation, apoptosis, stress responses, signaling, transcription, and translation. O-GlcNAc also plays pivotal roles in diseases, such as diabetes, neurodegenerative disease and cancer, and immunological regulation, such as T-cell activation. Through comparative proteomic analysis of resting and activated T-cells, we identified potentially GlcNAcylated proteins involved in post-signaling events of T-cell activation. O-GlcNAc on 58 proteins involved in processes, such as DNA replication, cytoskeletal rearrangement, chromatin remodeling, and RNA processing, were altered by T-cell activation. GlcNAcylation and phosphorylation are similar in abundance and cellular/ biological function, and their regulation is deeply intertwined. The two modifications regulate each other at the sitelevel by reciprocally influencing site-occupancy, and at the enzymatic-activity level by each modification modulating the catalytic activity of the enzymes involved in the other modification. This paper will focus on recent developments in the interplay between O-GlcNAc and phosphorylation, and O-GlcNAc's roles in human disease and immunology.
AB - GlcNAcylation is a dynamic cytoplasmic and nuclear post-translational sugar modification of serine/threonine residues. The addition and removal of O-GlcNAc are regulated by O-GlcNAc Transferase and O-GlcNAcase, respectively. Over ~1000 proteins have been identified to be GlcNAcylated with over 240 mapped sites. O-GlcNAc is involved in critical cellular functions, such as cell-cycle regulation, apoptosis, stress responses, signaling, transcription, and translation. O-GlcNAc also plays pivotal roles in diseases, such as diabetes, neurodegenerative disease and cancer, and immunological regulation, such as T-cell activation. Through comparative proteomic analysis of resting and activated T-cells, we identified potentially GlcNAcylated proteins involved in post-signaling events of T-cell activation. O-GlcNAc on 58 proteins involved in processes, such as DNA replication, cytoskeletal rearrangement, chromatin remodeling, and RNA processing, were altered by T-cell activation. GlcNAcylation and phosphorylation are similar in abundance and cellular/ biological function, and their regulation is deeply intertwined. The two modifications regulate each other at the sitelevel by reciprocally influencing site-occupancy, and at the enzymatic-activity level by each modification modulating the catalytic activity of the enzymes involved in the other modification. This paper will focus on recent developments in the interplay between O-GlcNAc and phosphorylation, and O-GlcNAc's roles in human disease and immunology.
KW - Crosstalk
KW - Disease
KW - GlcNAcylation
KW - Lymphocyte
KW - O-GlcNAc
KW - Phosphorylation
UR - http://www.scopus.com/inward/record.url?scp=77951895701&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951895701&partnerID=8YFLogxK
U2 - 10.2174/157436210790226528
DO - 10.2174/157436210790226528
M3 - Article
AN - SCOPUS:77951895701
SN - 1574-3624
VL - 5
SP - 25
EP - 40
JO - Current Signal Transduction Therapy
JF - Current Signal Transduction Therapy
IS - 1
ER -